greeksoup/ stock research

Bruker (BRKR) FY2021 results: revenue $2.4 billion, up 21.7% on the year

Bruker Corp. (BRKR) reported revenue of $2.4 billion for fiscal 2021, the year ended 31 December 2021, up 21.7% on the year before. Net income was $277 million, up 75.6%, and diluted earnings per share $1.81. The figures are the company's own, from the 10-K it filed with the SEC on 28 February 2022.

Revenue
$2.4 billion
+21.7% on the year
FY2014FY2021
Operating margin
17.1%
12.5% a year earlier
FY2014FY2021
Net income
$277 million
+75.6% on the year
FY2014FY2021
Diluted EPS
$1.81
+77.5% on the year
FY2014FY2021

this yearthe year beforeHover a bar for its figure.

The year in brief

The quarters: Q4 FY2021

Income statement (profit and loss)

$ millionFY2021FY2020FY2019On the yearLast 8 years
Revenue2,4181,9882,073+21.7%
Cost of revenue1,2081,0481,077+15.3%
Gross profit1,210940995+28.7%
Gross margin50.0%47.3%48.0%
Research and development221198188+11.5%
Selling, general and administrative561469500+19.8%
Operating income413248301+66.5%
Operating margin17.1%12.5%14.5%
Interest expense14.314.416.0-0.7%
Pre-tax income394226280+74.3%
Income tax11364.482.4+75.5%
Effective tax rate28.7%28.5%29.4%
Net income277158197+75.6%
Net margin11.5%7.9%9.5%
Diluted EPS$1.81$1.02$1.26+77.5%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2021FY2020FY2019On the yearLast 8 years
Operating cash flow282332213-15.0%
Capital expenditure92.097.273.0-5.3%
Free cash flow190235140-19.0%
Free cash flow margin7.9%11.8%6.8%
Cash from investing-192-193-158
Cash from financing319-162300
Depreciation and amortisation89.180.475.6+10.8%
Share-based compensation17.216.09.6+7.5%
Buybacks153123142+24.4%
Dividends paid24.224.625.0-1.6%
Dividend per share$0.16$0.16$0.160.0%
Diluted shares, weighted153m155m157m-1.1%
Shares outstanding at period end151m152m154m-0.8%

Balance sheet

$ millionFY2021FY2020FY2019On the yearLast 8 years
Shareholders' equity1,070961907+11.4%
Non-controlling interest14.113.110.3+7.6%
Redeemable equity0.20.021.1
Debt1,334844813+58.0%
Operating lease liabilities41.847.047.0-11.1%
Finance lease liabilities2.62.61.10.0%
Other liabilities1,1871,181972+0.5%
Total liabilities and equity3,6503,0492,772+19.7%
Fixed assets406396306+2.7%
Goodwill340320293+6.0%
Intangible assets212229233-7.6%
Investments10050.06.6+100.0%
Cash and equivalents1,068682678+56.7%
Receivables417335362+24.3%
Inventory710692577+2.6%
Other assets397345315+15.3%
Total assets3,6503,0492,772+19.7%

10-K for the year ended 31 December 2021, filed 28 February 2022: the filing.